• Ascendis Pharma Receives Positive CHMP Opinion for TransCon™ PTH (palopegteriparatide) for Adults with Chronic Hypoparathyroidism

    المصدر: Nasdaq GlobeNewswire / 14 سبتمبر 2023 11:22:57   America/Chicago

    N/A
شارك على،